Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-06-20

Clinical Trial Update: Effectiveness of Lobeline in Treating Symptoms of ADHD in Adult Patients [Phase 2]

View source ↗

Summary

A completed Phase 2 trial evaluated the effectiveness of lobeline in treating symptoms of attention-deficit/hyperactivity disorder in adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lobeline (lobeline)

Snippet

Sponsor: Yaupon Therapeutics | Conditions: Attention Deficit Disorder With Hyperactivity | Phase 2 | Status: COMPLETED